Explore
Validate
Learn26772-1-AP
antibody from Proteintech Group
Targeting: IL24
C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26772-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- IL-24 antibody
- Antibody type
- Polyclonal
- Description
- IL-24 antibody (Cat. #26772-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Tumor-Derived CCL16 Normalizes Tumor Vasculature through Macrophage ICAM-1 Receptor and Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma.
Single-cell RNA sequencing and spatial transcriptomics of esophageal squamous cell carcinoma with lymph node metastases.
EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis.
Vinburnine potentiates anti-PD1 immunotherapy in melanoma through IL-24 secretion via P38/MAPK/ATF3 signaling.
Targeting PRSS23 with tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3/p38 MAPK-IL24 pathway.
Serum IL-24 combined with CA125 as screening and prognostic biomarkers for NSCLC.
A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis.
ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity.
Chen K, Feng H, Zhang Y, Pei J, Xu Y, Wei X, Chen Z, Feng Z, Cai L, Li Y, Zhao L, Pan M
Cancer research 2025 Oct 1;85(19):3633-3650
Cancer research 2025 Oct 1;85(19):3633-3650
Single-cell RNA sequencing and spatial transcriptomics of esophageal squamous cell carcinoma with lymph node metastases.
Guo W, Zhou B, Dou L, Guo L, Li Y, Qin J, Wang Z, Huai Q, Xue X, Li Y, Ying J, Xue Q, Gao S, He J
Experimental & molecular medicine 2025 Feb;57(1):59-71
Experimental & molecular medicine 2025 Feb;57(1):59-71
EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis.
Peng HY, Chang KY, Chang WM, Wu CY, Lee HL, Chang YC, Liu KJ, Shiah SG, Kuo CC, Chang JY
Neoplasia (New York, N.Y.) 2025 Aug;66:101193
Neoplasia (New York, N.Y.) 2025 Aug;66:101193
Vinburnine potentiates anti-PD1 immunotherapy in melanoma through IL-24 secretion via P38/MAPK/ATF3 signaling.
Zhu S, Zhang X, Liu W, Zhou Z, Xiong S, Chen X, Peng C
Journal of experimental & clinical cancer research : CR 2025 Aug 27;44(1):255
Journal of experimental & clinical cancer research : CR 2025 Aug 27;44(1):255
Targeting PRSS23 with tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3/p38 MAPK-IL24 pathway.
Xiong JX, Li YT, Tan XY, Chen T, Liu BH, Fu L
Acta pharmacologica Sinica 2024 Feb;45(2):405-421
Acta pharmacologica Sinica 2024 Feb;45(2):405-421
Serum IL-24 combined with CA125 as screening and prognostic biomarkers for NSCLC.
Zhang K, Qu J, Deng S, Yuan E
Cell biology international 2024 Aug;48(8):1160-1168
Cell biology international 2024 Aug;48(8):1160-1168
A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis.
Li J, Qin X, Shi J, Wang X, Li T, Xu M, Chen X, Zhao Y, Han J, Piao Y, Zhang W, Qu P, Wang L, Xiang R, Shi Y
eLife 2021 Jun 11;10
eLife 2021 Jun 11;10
ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity.
Zhang L, Wang Y, Li X, Xia X, Li N, He R, He H, Han C, Zhao W
Neoplasia (New York, N.Y.) 2017 Nov;19(11):908-918
Neoplasia (New York, N.Y.) 2017 Nov;19(11):908-918
No comments: Submit comment
No validations: Submit validation data